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Abstract
Background: Tobacco smoke (TS) contains highly reactive oxygen species (such as hydrogen peroxide,
peroxynitrite, etc), which cause oxidative damage in vascular tissue and may exacerbate inflammatory events
leading to the blood-brain barrier damage (BBBD) which accompanies the development of a variety of
neurological disorders. Smokers often have elevated leukocyte counts (primarily neutrophils and monocytes), and
significant decreases in plasma alpha-tocopherol (vitamin E) and ascorbic acid (vitamin C) levels due to increased
anti-oxidative mobilization in response to oxidative stress evoked by TS. For this purpose, using static culture
systems and a well-established dynamic in vitro BBB model (DIV-BBB) we tested the hypothesis that antioxidant
vitamin supplementation (E and/or C) can protect the BBB during exposure to whole soluble TS.
Results: TS exacerbates inflammatory events and leads to endothelial overexpression of vascular adhesion
molecules (VCAM-1, P-selectin and E-selectin), release of pro-inflammatory cytokines (TNF-a and IL-6) and nitric
oxide (NO), release and activation of matrix metalloproteinases (MMP-2 and MMP-9), monocytic maturation into
macrophages, and adhesion to the vascular endothelium. Furthermore, TS altered the normal glucose metabolic
behaviour of in vitro BBB capillaries and caused a period of transient anaerobic respiration to meet the cellular
bioenergetic demand. Pre-treatment with antioxidant vitamins (C and/or E) effectively reduced the pro-
inflammatory activity associated with TS, protecting the viability and functions of the BBB.
Conclusion: Our results have shown that loss of endothelial viability as well as BBB function and integrity caused
by TS exposure can be prevented or at least reduced by normal physiologic concentrations of antioxidant vitamins
in vitro.
Background
Tobacco Smoke affects vascular endothelial physiology
Active and passive tobacco smoke are associated with
dysfunction of vascular endothelial physiology [1-13] in
a causative and dose-dependent way. In the brain, TS
increases the risk of silent cerebral infarction (SCI) [14]
and stroke which by approximately 50% [15,16] due to
its; pro-coagulant and atherogenic effects [17,18]. The
risk increases proportionally with the number of cigar-
ettes smoked [19]. Furthermore, oxidative stress caused
by the exposure to TS can facilitate the pathogenesis
and progression of several neurological disorders
including Parkinson’sa n dA l z h e i m e r ’s diseases [20-24].
Previous study has shown that chronic smokers have a
higher incidence of small vessel ischemic disease (SVID)
than non-smokers [25]. SVID is a pathological condition
characterized by leaky brain microvessels and loss of
BBB integrity. Since TS generates superoxide and other
ROS, some of the adverse effects of smoking may result
from oxidative damage to ECs, [4,12,13,26-29], which
may be aggravated by nitric oxide (NO) and antioxidant
depletion (e.g., ascorbic acid). Recent observations
strongly suggest that ROS are key mediators of BBB
breakdown [25,26,30-33].
While the harmful effects of smoking on public health
have been well demonstrated and detailed in many
organs, the BBB has received much less attention
despite the strong evidence for an association between
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recently published data [25] have shown that TS pro-
motes the pro-inflammatory activation of BBB EC and
the release of pro-inflammatory mediators. This
occurred in the absence of other pro-inflammatory sti-
muli and independently from the presence of peripheral
blood cells. Furthermore; TS can significantly exacerbate
t h el o s so fB B Bi n t e g r i t yc a u s e db yc o n c u r r e n tc e r e b r o -
vascular rheological alterations, [25,35] facilitating the
further pathogenesis and progression of secondary brain
injuries.
Tobacco smoke: A harmful cloud of Free Radicals
The role of free radicals in the pathogenesis of smoking-
related diseases has been substantiated by a large num-
ber of studies. A free radical is a highly unstable and
reactive molecule containing one or more unpaired elec-
trons. Free radicals, despite being essential for biological
systems [36] have a potential to cause extensive oxida-
tive damage to cells and tissues if their levels become
excessive [21,22,27,37-41]. At the vascular level free
radicals can lead to oxidative damage of endothelial cells
[12,13] (e.g., DNA strand breakage [3,42-44]) and
inflammation [3]. Free radicals arise normally during
cell metabolic activity and are also purposefully pro-
duced by immune cells to neutralize potentially harmful
pathogens such as bacteria and viruses. In vivo,u n d e r
normal circumstances the oxidative stress caused by
naturally generated free radicals is counterbalanced by
antioxidants [45,46] (e.g., alpha-tocopherol, ascorbic
acid, beta-carotene, glutathione, catalase, superoxide dis-
mutase, etc.). However, environmental factors including
active and passive tobacco smoking (a major exogenous
source of free radicals contained in both gas phases and
tar [47-49]) can spawn these highly reactive oxygen spe-
cies (ROS; e.g., hydrogen peroxide, epoxides, nitric oxide
(NO), nitrogen dioxide, peroxynitrite (ONOO-), etc
[49]) beyond the levels which the human body can elim-
inate effectively. In fact, several studies have shown that
1) chronic smokers suffer of antioxidants shortage
caused by the increased demand that the ROS derived
from TS place on their cells [13,50,51]; 2) antioxidant
supplementation reduces the oxidation and inflamma-
tion induced by tobacco smoke in animals and cells
[13,50,52-55]. In response to these studies, the Food and
Nutrition Board of the National Academy of Sciences
has established a higher Recommended Dietary Allow-
ance (RDA) of vitamin C for smokers, (more than 200
mg/day) versus the recommended 90 mg/day for non-
smokers.
Is there a role for Antioxidant Vitamins Supplementation?
Antioxidants such as vitamin C (ascorbic acid) and E
(a-tocopherol) are compounds that hinder the oxidative
processes and thereby delay or prevent oxidative stress.
Although there is still no unequivocal evidence that an
increased intake of antioxidant nutrients can fully coun-
teract TS toxicity, there are many supporting data sug-
gesting that antioxidants may prove to be effective
scavengers of exogenous-derived ROS [56]. Previously,
vitamin C has been shown to act not only as a potent
reducing agent but also to play a role (currently not yet
clearly understood) in modulating the production of
lymphocytes and cytokines, the activity of phagocytes,
and the expression of a number of cell adhesion mole-
cules in monocytes [57]. Furthermore, vitamin C seems
to prevents histamine release and increases the detoxifi-
cation of histamine [58], thus acting as an anti-inflam-
matory agent as well as a potent antioxidant.
Considering the major role played by ROS in the patho-
genesis of BBB impairment as well as that of neurologi-
cal disorders [21-23,32,59] we evaluated the
independent and complementary effectiveness of antiox-
idants vitamins supplementation, such as vitamin C
(protection against protein oxidation [60-62] and vita-
min E (counteract lipid peroxidation [63-65]), in shield-
ing the BBB from the chronic exposure to TS-generated
oxidative stress.
Results
Tobacco Smoke pro-inflammatory response induced in
brain microvascular endothelial cells was reduced by
antioxidant vitamins supplementation
Chronic exposure of confluent cultures of human brain
microvascular endothelial cells (HBMEC) to TS (equiva-
lent to 20 cigarettes/day; see in Material and Methods
for details) resulted in a significant increase in the num-
ber of HBMEC cells expressing the pro-inflammatory
adhesion molecules P-selectin, VCAM-1 and E-selectin
the expression levels of P-selectin, VCAM-1 and E-
selectin (112.5% ± SEM 8.2, 144.5% ± SEM 6.3, and
84.3% ± SEM 12.4 respectively) as compared to sham-
smoke-exposed controls (Figure 1A). The augmented
expression of these pro-inflammatory adhesion mole-
cules was paralleled by over a 10 fold increase (from 9.1
± SEM 2.1 to 103.3 ± SEM 4.3 pg/mL) of interleukin-6
(IL-6) levels in the medium, and over a 2 fold increase
in that of t u m o rn e c r o s i sf a c t o r -alpha (TNF-a)( f r o m
25.8 ± SEM 4.5 to 67.2 ± SEM 9.0 pg/mL). IL-1b levels
were unaffected (Figure 1B). Exposure to TS also
increased the release of matrix metalloproteinases-2
(MMP-2) from 775 ± SEM 98 to 4344 ± SEM 235 pg/
mL. No release of MMP-9 was detected (Figure 1C).
Gelatin zymography of electrophoresed medium samples
showed a small (28.3 ± SEM 9.0%) yet significant
increase in MMP-2 activity 15 minutes following TS
exposure, which substantially increased to 132.7 ± SEM
14.3% at 60 minutes (Figure 1D).
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logical concentrations ≅ 80 and 40 μM respectively) sig-
nificantly reduced the pro-inflammatory activity of TS
on HBMEC. Specifically the over-expression of endothe-
lial adhesion molecules during TS exposure (Figure 1A)
was significantly reduced. This was paralleled by a
decrease in the release of IL-6 and TNF-a (Figure 1B).
MMP-2 release (Figure 1C) and activity (Figure 1D)
were reduced in cultures pre-treated with vitamin E and
E+C (combined treatment) but not vitamin C alone.
Figure 1 Antioxidant vitamins administration reduced TS-dependent the pro-inflammatory activation of BBB endothelial cells. Chronic
exposure of confluent cultures of HBMEC to TS levels equivalent to 20 cigarettes/day increased the number of HBMEC cells expressing of
endothelial adhesion molecules E-selectine, P-selectine and VCAM-1. However, the pro-inflammatory effect of TS was partially counteracted by
pre-treatment with the antioxidant vitamin C and E (Panel A), which as expected reduced the overall release of pro-inflammatory cytokines IL-6
and TNF-a (Panel B). MMP-2 release and activity were also significantly augmented by TS exposure (Panel C). MMP-2 release and activation
following TS exposure were most effectively prevented by vitamin C and E co-administration. All the described experiments were performed in
quadruplicates (n = 4). The asterisk “*” indicates a statistically significant difference (p < 0.05) versus control. Multiple asterisks indicate a
statistically significant difference (p < 0.05) versus other treatments. The plus sign “+” indicates a statistically significant difference (p < 0.05)
versus the control as well as all the other treatments.
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tive protection against TS exposure.
Monocytes activation by Tobacco Smoke was partially
inhibited by pre-treatment with vitamin C and/or vitamin
E
Our results showed a very marked increase of TNF-a
( f r o m0 . 8 1±S E M0 . 1 4t o1 6 3 . 1 1±S E M7 . 8 3p g / m L )
and IL-1b (from 0.66 ± SEM 0.21 to 113.59 ± SEM 8.15
pg/mL) levels in the culture medium of THP-1 mono-
cytes upon exposure to TS (see in Materials and Meth-
ods for details) (Figure 2A). IL-6 level was only
moderately effected but the difference was not statisti-
cally significant. In parallel, we observed a significant
increase in the medium levels (Figure 2B) of MMP-9
and MMP-2 (from 285.71 ± SEM 22.44 to 596.55 ±
SEM 49.68 pg/ml and from 1638.56 ± SEM 1095.34 to
12089.50 ± SEM 912.28 pg/mL respectively). Increased
MMPs activity (MMP-2 and MMP-9) was already evi-
dent after 15 minutes of TS exposure (62.9 ± SEM 4.4%
and 26.4 ± SEM 3.8% respectively; see Figure 2C) and
became significantly more prominent at 60 minutes
(151.9 ± SEM 8.8% and 60.5 ± SEM 5.6% respectively).
TS-triggered release of pro-inflammatory cytokines
was most significantly reduced by pre-treatment with
vitamins C and E. In contrast to vitamin C, vitamin E
alone also demonstrated significant anti-inflammatory
protection.
The TS-induced release of MMP-2 and MMP-9 was
also decrease by the antioxidant vitamins however, there
were no statistical significant differences in terms of effi-
cacy between individual (Vit. C or E) and combined pre-
treatments. By contrast, the most effective blockade of
MMPs activation was attained using combined (C + E)
vitamins supplementation (Figure 2C). Vitamin E alone
was also effective while only short term MMPs activity
r e d u c t i o nw a so b s e r v e dw h e nu s i n gv i t a m i nC( F i g u r e
2C left panel).
Antioxidant vitamins reduced endothelial-monocytes
adhesion and synergistically decreased the release of pro-
inflammatory mediators during TS exposure
HBMEC and THP-1 cells cultures were individually
exposed to TS as described above. Parallel sham-smoke
cultures were used as control. After the TS exposure
cycle was completed, the wells containing the endothe-
lial cells underwent a wash out and medium replace-
ment using a TS-free one. In parallel, THP-1 cells were
isolated by centrifugation, then re-suspended (2 × 10
5
cells/mL) with the endothelial cells and left to undergo
adhesion for one hour without agitation. Non-adherent
monocytes were then washed away by gentle shaking
and the medium was collected for a content analysis of
pro-inflammatory mediators (cytokines and MMPs).
Visual inspection (Figure 3A upper panels) and quantifi-
cation of adherent monocytes (Figure 3A lower panel)
showed a dramatic increased in the percentage of mono-
cytes bonded to endothelial cells following TS exposure
(90.3 ± SEM 5.0%) in comparison to sham-smoke cul-
tures (23.6 ± SEM 5.2%). Pre-treatment with normal
physiological concentrations of vitamins E and (to a les-
ser extent) C reduced the percentage of adherent cells
in TS pre-exposed cultures (66.2 ± SEM 4.6% and 47.4
± SEM 6.7% respectively). The combined pre-treatment
with both vitamin E and C was the most effective (36.8
± SEM 4.0%). As previously observed in addition to
enhanced endothelial-monocytes adhesion, TS exposure
lead to a significant increase in the medium content of
IL-1b, IL-6 and TNF-a (0.58 ± SEM 0.5 to 112.2 ± SEM
29.01; 5.01 ± SEM 2.2 to 109.3 ± SEM 33.7; 62.5 ± SEM
29.8 to 328.6 ± SEM 34.9 pg/mL respectively). Antioxi-
dant vitamin pre-treatment was effective (at various
levels) in reducing the TS-induced release of these pro-
inflammatory cytokines (Figure 3B1). As expected, cul-
ture medium analysis showed that the interaction
between TS-activated THP-1 cells with TS-activated
HBMEC prompted a synergistic increase in the release
and activation of MMP-2 and MMP-9 (Figure 3B2 and
3B3). Vitamin C reduced the release of MMP-2 and
MMP-9 but was ineffective in blocking their corre-
sponding activation as demonstrated by the zymogram
gel analysis of medium content (Figure 3B3, upper
panel). By contrast the anti-inflammatory protection
provided by vitamin E and the combined treatment (C +
E) were significantly more effective.
Ascorbic acid and a-tocopherol protect the BBB viability
from the harmful exposure to Tobacco Smoke
The effect of TS exposure (equivalent to that generated
by 5, 20, and 35 cigarettes/day (5C, 20C, 35C) respec-
tively) on BBB integrity was evaluated fully established
DIV-BBB [66-68] modules (Figure 4A). Sham-TS-
exposed modules were used as control. TS levels equiva-
lent to 5C did not significantly impaired BBB integrity
as demonstrated by TEER (Figure 4A left panel) and
Adenylate kinase (AK) release measurements (Figure
4B). In contrast, exposure to higher TS levels (20 and
35C) resulted in rapid and dose-dependent loss of BBB
integrity, which was accompanied by a significant
increase of AK release when compared to controls, and
to the release of AK that followed the exposure to a low
level of TS (Figure 4A and 4B). We assessed the protec-
tive efficacy of antioxidant vitamins against the BBB
exposure to TS levels equivalent to 20C/day. BBB integ-
rity was partially protected against TS exposure-related
damage by vitamin E and C as demonstrated by TEER
(Figure 4C) and AK release (Figure 4D) measurements.
The independent administration of these substances
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Page 4 of 18Figure 2 Administration of vitamins E and C reduced the immune activation of monocytes and the subsequent release of pro-
inflammatory mediators during TS exposure. Chronic TS induced a marked increase in the medium content of IL-1b and TNF-a (Panel A),
which were partially offset by the administration of antioxidant vitamins E and C. The medium content (Panel B) and activity (Panel C) of MMP-2
and-9 was also substantially increased by TS exposure. However, this was partially counteracted by vitamin E pre-treatment (alone) and vitamin E
in combination with vitamin C. Vitamin C alone was only marginally effective. All the described experiments were performed in quadruplicates
(n = 4). The asterisk “*” indicates a statistically significant difference (p < 0.05) versus control. Multiple asterisks indicate a statistically significant
difference (p < 0.05) versus other treatments. The plus sign “+“ indicates a statistically significant difference (p < 0.05) versus the control as well
as all the other treatments.
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Page 5 of 18Figure 3 Antioxidant vitamins reduced the synergistic pro-inflammatory activation on HBMEC in presence of THP-1 cells during TS
exposure. Visual inspection and quantification of adherent monocytes showed a dramatic increase in the number of monocyte-endothelial
bonded cells following TS exposure (Panel A). Leukocyte-endothelial interactions during TS exposure were prevented by pre-treatment with
physiological concentrations of vitamins E and (to a lesser extent). Analysis of the medium content showed that pre-treatment with antioxidant
vitamins tested herein also reduced the release of IL-1b, IL-6 and TNF-a (Panel B1), that of MMP-2 and MMP-9 (Panel B2) and also reduced the
MMP-2 and -9 activation (Panel B3). Note that the anti-inflammatory protection provided by pre-treatment with vitamin E alone and that of
vitamin E and C combined, was significantly more effective (by magnitude and duration) than that of vitamin C alone. All the described
experiments were performed in quadruplicates (n = 4). The asterisk “*” indicates a statistically significant difference (p < 0.05) versus control.
Multiple asterisks indicate a statistically significant difference (p < 0.05) versus other treatments. The plus sign “V” indicates a statistically
significant difference (p < 0.05) versus the control as well as all the other treatments.
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Page 6 of 18Figure 4 Antioxidant vitamins protect against TS-dependent loss of BBB viability and integrity. Under the exposure to pulsatile flow in
presence of abluminal astrocytes and circulating THP-1 cells the vascular endothelium formed a stable highly impermeable barrier (TEER ≈ 1200
Ohm/cm
2)( Panel A -left). Exposure to TS at concentrations equivalent to yield by 20 cigarettes/day or more higher caused a loss of BBB
integrity (Panel A -right) which was paralleled by a significant and proportional (to TS exposure) release of AK (Panel B). The loss of BBB
integrity during TS exposure (≅ 20 cigarettes) was most significantly reduced by the combined pre-treatment with vitamins C and E (Panel C)a s
also demonstrated by the parallel decrease in AK release (Panel D) and that of pro-inflammatory mediators IL-1b, IL-6 and TNF-a (Panel E). The
described experiments were performed in quadruplicates (n = 4).
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Page 7 of 18resulted in a delayed and a less severe loss of BBB viabi-
lity. Note that the co-administrations of these vitamins
provided the most significant protection. In addition to
BBB deterioration during TS exposure, the analysis of
the media samples showed a statistically significant
increase in the levels of IL-1b,I L - 6 ,a n dT N F - a (Figure
4E). Administration of antioxidant vitamins significantly
reduced the TS-induced release of these pro-inflamma-
tory cytokines with the combo approach being the most
effective.
Hydrogen peroxide impairs BBB integrity: Protective role
of antioxidant vitamins
The effect of hydrogen peroxide (H2O2, one of the many
redox active substances contained in cigarette smoke; 2-
4 μ MH 2O2/mg of tar [69,70]) exposure on BBB integ-
rity was assessed in the DIV-BBB. Three levels of H2O2
exposure comparable to that yield by 5, 20, and 35 2R24
research cigarettes (55, 220, and 385 μM respectively)
were tested. Sham- H2O2-exposed modules were used as
control. Exposure to H2O2 equivalent to that generated
by 5 cigarettes (55 μM) did not affect BBB integrity (Fig-
ure 5A-right panel) as demonstrated by TEER measure-
ments. In contrast, exposure to higher levels of H2O2
(110 and 220 μM respectively) resulted in rapid and
dose-dependent loss of BBB integrity. Pre-treatment
with vitamin E and C provided only a partial protection
against oxidative damage to the BBB (Figure 5B). Note
that the efficacy of the antioxidative protection was
assessed against the effect of the highest of the 3 levels
of H2O2 exposure (220 μ M). Co-administration of vita-
mins C and E fully prevented the loss of BBB integrity
and viability.
Tobacco smoke can impair BBB viability through
alteration in nitric oxide bioavailability
NO release by TS and by the vascular endothelium was
assessed in real time by amperometric determination
through electrode(s) in contact with the luminal and the
abluminal compartments of the DIV-BBB modules. We
determined a sudden and transient increase in the med-
ium levels of NO (Figure 6A) in BBB modules exposed
to TS versus sham systems, which correlated with the
concentration of TS (0.5, 2.0, 3.5 cigarettes/hour for 1
h o u ry i e l d e d4 0 ,6 0a n d1 0 0p / A m pN Op e a k sr e s p e c -
tively). NO started declining immediately after reaching
the peak level. However, the NO decline was negligible
in DIV-BBB modules pre-treated with antioxidant vita-
mins C and E.
During the recovery time (in the absence of TS) we
observed a diametric decrease of NO, which also corre-
lated with the concentration of TS to which the corre-
sponding BBB modules were initially exposed (Figure
6A). NO remained below the baseline level for ≈ 23
hours before returning to normal. Pre-treatment with
vitamins C and E did not prevent the reduction of NO
bioavailability nor accelerated the return to a baseline
level (Figure 6B).
Tobacco smoke can alter the normal BBB bioenergetic
metabolism: role of antioxidant vitamins
Under normal physiological conditions BBB endothelial
cells are characterized by a predominant oxygen-
depended bioenergetic metabolism (aerobic) [66,71].
The increased demand for reducing equivalents (e.g.,
NADH, FADH2, etc.; normally utilized during oxidative
respiration) to neutralize the reactive oxidative species
from TS can cause metabolic alterations in the BBB
endothelium [71]. As shown in Figure 7A (left panel)
glucose consumption and lactate production levels were
stable during the pre-TS phase treatment with a meta-
bolic index (ratio between lactate production and glu-
cose consumption) ≅ 1 (Figure 7A right panel).
Administration of vitamins C and E at physiological
concentrations (80 μMa n d4 0μM respectively) did not
alter the metabolic behaviour of the BBB. However,
exposure to TS (cycles of chronic exposure: every other
hour for 12 hours/day) caused a decrease in glucose
consumption (see Figure 7B left panel) and an unparal-
leled increase in lactate production, demonstrating a
shift toward predominantly anaerobic bioenergetic meta-
bolism (metabolic index ≅ 0.7; see Figure 7B right
panel). Co-administration of vitamins C and E gradually
restored the bioenergetic metabolism of the BBB.
Discussion
The BBB maintains brain homeostasis and selectively
excludes most blood-borne and xenobiotic substances
from entering the brain, protecting it from systemic and
exogenous influences [72,73]. Deterioration in BBB
functions have been clearly shown to play a major role
in the pathogenesis and progression of a steadily
increasing number of neurological disorders such as
multiple sclerosis, Alzheimer’s disease, neoplasia, hyper-
tension, dementia, epilepsy, infection, and trauma [74].
While the harmful effects of smoking on public health
have been well demonstrated and detailed in many
organs, the BBB has received much less attention
despite the strong evidence for an association between
tobacco smoke and vascular impairment. Recently pub-
lished data [25] have shown that TS negatively affects
vascular endothelial physiology and directly promotes
the pro-inflammatory activation of BBB endothelium.
Many of the over 4000 components contained in TS
are thought to facilitate the development of a proathero-
sclerotic environment [25,28,75-77] by triggering a com-
plex pro-inflammatory response. This is mediated by the
recruitment of leukocytes through cytokine signalling (e.
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metalloproteinase upregulation (e.g., MMP-1, MMP-8,
and MMP-9), and by promoting the adherence of
monocytes to the endothelial wall [25,78].
TS’s status as a powerful pro-inflammatory agent is
suggested by the observation of elevated levels of white
blood cells, primarily neutrophils and monocytes, in
smokers [79]. Elevated C-reactive protein (CRP) levels
caused by TS promotes endothelial dysfunction by low-
ering the production of NO and diminishing its
bioactivity [80], thereby limiting the smoker’s ability to
vasodilate via NO release.
One well accepted yet poorly understood mechanism
by which smoking can directly hamper BBB viability and
function relays upon oxidative stress caused by the
many highly reactive oxygen species and free radicals of
which TS is highly enriched. The gas-phase of tobacco
smoke alone is a complex mixture of high concentra-
tions of ROS and free radicals (approximately one quad-
rillion radicals per puff [81]). This represents an
Figure 5 Exposure to hydrogen peroxide affects BBB viability and integrity. (Panel A) Under the exposure to pulsatile flow in presence of
abluminal astrocytes the vascular endothelium formed a stable highly impermeable barrier (TEER ≈ 1200 Ohm/cm
2)( Panel A left side). Exposure
to H2O2 equivalent to that contained in 10 and 20 cigarettes determined a loss of BBB integrity (Panel A right side). Loss of BBB integrity and
viability at the highest H2O2 level of exposure was partially prevented to a different extent by pre-treatment with antioxidant vitamins (C, E, and
combined treatment, Panel B). The described experiments were performed in quadruplicates (n = 4). The asterisk “*” indicates a statistically
significant difference (p < 0.05) versus control. Multiple asterisks indicate a statistically significant difference (p < 0.05) versus other treatments.
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Page 9 of 18Figure 6 Amperometric determination of NO during and after TS exposure.( Panel A) Note the transient surge in the medium levels of NO
immediately after TS exposure followed by a steady decline that brought the NO to below baseline levels during the recovery time. (Panel B)
Pre-treatment with vitamins C and E did not prevent the reduction of NO bioavailability nor accelerated the return to a baseline level but
reduced the NO decline during the initial phase of TS exposure (Panel A -right). Please note that reading conversion of the NO sensors was ≅
1.5pA/nM ± 3%. The described experiments were performed in quadruplicates (n = 4).
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lead to BBB breakdown by oxidative damage, tight junc-
tion (TJ) modification, and matrix metalloproteinases
(MMP) activation [32]. The results presented herein
suggest that antioxidant vitamins may provide an effec-
tive shielding against oxidative stress thus, protecting
the BBB during TS exposure.
Our data have shown that the administration of phy-
siological concentration of vitamin E and/or C reduced
the BBB endothelial pro-inflammatory activation soli-
c i t e db yT Se x p o s u r e( s e eF i g u r e1 ) .W h i l et h ep r e c i s e
mechanism/s by which TS triggers an immune vascular
response at the BBB cannot be determined from these
experiments, our data strongly suggest that: 1) the
imbalance between tissue/plasma concentrations of anti-
oxidants and reactive oxygen species caused by TS
played a major role in the process; 2) this can be par-
tially prevented by administration of antioxidant
vitamins.
The BBB endothelium is not the only tissue affected
by TS. Our data also showed that TS directly activated
monocytes which resulted in the release of IL-1b and
TNF-a and MMPs (see Figure 2). We also observed a
time dependent increase in the activity of MMP-2 and
MMP-9 which initiated as early as 15 minutes of TS
exposure and increased substantially after 60 minutes.
Figure 7 BBB glucose metabolism is affected by TS exposure. The ratio between glucose consumption and lactate production is not
affected by vitamins supplementation (C+E) (Panel A). Note that a glucose consumption/lactate production ratio ≈ 1 indicates that at list 50%
of glucose undergoes oxidative metabolism (Krebs cycle). TS caused a decrease in glucose consumption paralleled by an in lactate production
(Panel B) suggesting that a shift toward a non-oxidative glucose metabolism occurred. This metabolic shift was gradually reversed by
antioxidant vitamins supplementation (C+E). The asterisk “*” indicates a statistically significant difference (p < 0.05) versus control. The described
experiments were performed in quadruplicates (n = 4).
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reflected the continuous release of these enzymes during
TS exposure suggesting an ongoing pro-inflammatory
stimulation of the cells. Similar to what observed in BBB
ECs cultures, pre-treatment with antioxidant vitamins
reduced monocytes pro-inflammatory activation by TS.
In this study we used a final concentration of vitamin
C( 8 0μM) equivalent to that found independently of
gender in healthy non-smoker subject (35.3-107.1 μM;
6.2-18.8 mg/L ) according to literature data [82]. Not
surprisingly the anti-inflammatory activity of vitamin C
was limited to the initial 15 minutes of TS exposure.
Vitamin C is an hydrophilic reducing agent making it
the first line of defense against ROS and the first to be
consumed in the process. Therefore, it very likely that
higher concentrations and/or a sustained supplementa-
tion of vitamin C are necessary to maintain a protective
effect for a longer period of time. This is agreement
with the decision of Food and Nutrition Board of the
National Academy of Sciences to raise the RDA of vita-
min C for smokers to over 200 mg/day (≅ 160 μM/l
cconsidering an estimated 70% absorption which
decreases as intake increases) versus the recommended
90 mg/day for non-smokers. This help counteracting
vitamin C depletion caused by TS-derived ROS over
time.
On the other hand, when vitamin C was co-adminis-
tered with vitamin E (a powerful fat soluble reducing
agent and the primary antioxidant present in the lipid-
rich cell membranes; see also Figure 3) the protective
effect was significantly enhanced both in efficacy and
duration. The interaction between vitamins E and C has
been recognized and extensively studied showing an
ascorbate-mediated regeneration of oxidized membrane
alpha-tocopherol back to itsr e d u c e df o r m .Ap r o c e s s
that extends the protective effect of vitamin E against
oxidative stress [83].
Whether ROS can directly hamper BBB viability was
also clearly demonstrated. Our results showed a time
and dose dependent loss of BBB viability when in the
absence of physiological antioxidants protection the
DIV-BBB modules were exposed to H2O2 levels compar-
able to those a chronic smoker is routinely exposed (see
Figure 5). Our findings are in agreement with studies by
others showing that plasma antioxidant vitamins (espe-
cially ascorbic acid) levels in chronic smokers are signifi-
cant decreased due to accelerated turnover in response
to TS-evoked oxidative stress [51]. This is also in agree-
ment with the fact that administration of antioxidant
vitamins C and E (particularly when combined) pre-
vented the loss of BBB integrity.
Not surprisingly, direct BBB exposure to TS showed
similar results. We observed a similar time and dose
dependent pattern of BBB impairment (see Figure 4A),
which was paralleled by the release of adenylate kinase
(a well-established marker of cell damage; see Figure
4B). This suggests that the increased paracellular perme-
ability is not exclusively dependent (at least in the short
term) on the exposure to nicotine [84] contained in TS
but also to cell damage caused by ROS. This hypothesis
is supported by the fact that pre-treatment with antioxi-
dant vitamins significantly reduced the loss of BBB via-
bility during TS exposure (see Figure 4C). This was
accompanied by a similar decreased in the release of AK
(see Figure 4D) and that of pro-inflammatory cytokines
(see Figure 4E). The latter is also in agreement with pre-
vious studies showing that vitamin C plays an important
(yet not fully understood) role in the modulation of
cytokines release as well as other immune surveillance
activities [57].
Another mechanism through which tobacco smoke
can impair BBB viability is through the alteration of
nitric oxide bioavailability. NO is a molecular mediator
involved in a variety of physiologic and pathological pro-
cesses. Three isoforms of NOS have been described:
neuronal NOS (nNOS), endothelial (eNOS) and induci-
ble or immunological NOS (iNOS). Vascular endothelial
cells generate small bursts of NO from L-arginine via
increase in intracellular Ca
2+ through a calcium-depen-
dent constitutive NO synthase (eNOS). In contrast,
iNOS induced in pathological/inflammatory state is Ca-
independent manner and releases NO continuously in
large amounts. Our data showed a sudden burst in NO
(see Figure 6A) immediately after the initial exposure to
tobacco smoke. Consequent to the sudden raise of NO
we observed a steady decline on NO levels which sug-
gests a rapid reaction of NO with other TS-released
ROS and its conversion in peroxynitrite (ONOO-) [85].
This hypothesis is in agreement with the fact that NO
decline was prevented by pre-administration of antioxi-
dant vitamins, which neutralized the ROS contained in
TS. This being the case, it is possible that antioxidant
treatments may indeed prolong the initial NO-depen-
dent vasodilatation experience by smokers during TS
exposure.
By contrast, during the recovery time (in the absence
of TS) NO dropped below the baseline level. The mag-
nitude of this decline appeared to be proportional to the
amount of TS to which the corresponding BBB modules
were previously exposed. While the precise mechanisms
by which TS affected NO bioavailability cannot be
entirely determined from these experiments, some infer-
ences can be still derived. Nicotine contained in TS has
been shown to inhibit eNOS activity, thus decreasing
the constitutive level of NO release by the vascular
endothelium [86,87]. As shown in Figure 6B pre-treat-
ment with antioxidant vitamins did not affect the
decline of NO during the recovery phase. This supports
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are responsible for the observed decline of NO during
this phase leading to vasoconstriction and aggravating
the vascular impairment of the brain [88,89].
Tobacco smoking has also been associated with
impairments of glucose metabolism and glycemic regu-
lation [90]. Our data have clearly shown that TS expo-
sure determined a decrease in glucose consumption
(Figure 7B left panel), paralleled by an increase in lactate
production. This is indicative of a potential change in
the BBB bioenergetic behaviour toward a more predomi-
nant anaerobic metabolism (see Figure 7B right panel).
The mechanisms through which TS affect glucose meta-
bolism may be related to free radicals and other ROS
contained in tobacco smoke [11]. In vivo, this effect can
be further exacerbated by the carbon monoxide (CO)
also contained in tobacco smoke. CO through binding
to hemoglobin, myoglobin and mitochondrial cyto-
chrome oxidase [91]can cause a relatively prolonged
impairment of glucose oxidative metabolism and a
decrease in glucose utilization [92,93]
One way through which BBB endothelial cells can try
to counteract the increased levels of ROS is through the
generation of reductant equivalents such as glutathione
peroxidase (of the principal antioxidant defense
enzymes). Generation of glutathione peroxidase requires
oxidized glutathione to be reduced by glutathione reduc-
tase using NADPH generated in the pentose phosphate
pathway (also called the phosphogluconate pathway).
This process generates NADPH (oxidative phase) and
pentoses (5-carbon sugars; non-oxidative synthesis) [11].
A shift toward the pentose phosphate pathway to com-
p e n s a t ef o rt h ee x c e s so fR O Sw o u l de x p l a i nt h e
reduced glucose consumption we observed during TS
exposure.
Furthermore, BBB endothelial cells could also use the
Krebs cycle reducing agents (normally utilized to sustain
the energy-producing pathway based on oxidative phos-
phorylation) to counteract TS-derived ROS. This would
leave the cellular mitochondria underequipped to sus-
tain the oxidative glucose metabolism and would explain
the increased lactate production also observed during
TS exposure. This hypothesis is supported by our data
which showed that administration of antioxidant vita-
mins C and E gradually restore the normal bioenergetic
metabolism of the BBB (see Figure 7B) [11,94]. How-
ever, a more specific and detailed study will be necessary
to confirm this hypothesis and unravel the underlining
mechanism/s.
Conclusion
Our data indicate that loss of endothelial viability as
well as BBB function and integrity in vitro caused by TS
exposure can be significantly reduced by pre-treatment
with physiologic concentrations of a-tocopherol and
ascorbic acid. These antioxidant vitamins may act syner-
gistically in preventing oxidative damage and pro-
inflammatory stimulation induced by tobacco smoking
exposure, thereby reducing TS toxicity at the BBB level.
Study limitations
In vitro toxicology studies of tobacco and tobacco
smoke have been used widely used to assess the toxico-
logic impact of tobacco product. However, there are
limitations with respect to the generality of the findings
inherited in such studies which reflect the inability of
any in vitro model to fully recapitulate the biological
and physiological make up a living organism. In this
study we used an artificial vascular system to assess the
effect of TS exposure on the BBB and whether adminis-
tration of vitamin C and/or E can reduce TS toxicity.
However, our model cannot reproduce for example, the
effect of hepatic clearance and peripheral metabolism on
the concentration of TS components to which the BBB
and the immune system are exposed. This can lead to a
relative over-exposure of the BBB and its constituents
(including circulating monocytes) to TS thus, exaggerat-
ing its acute harmful effects. In vitro studies on TS toxi-
city (such the one reported in here) more likely reflect
the impact of chronic smoking over a long period of
time (in general several years) were cumulative harmful
effect builds up overtime.
Methods
TS Preparation
Concentrated smoke solution was prepared from 2R4F
research cigarettes, which are high nicotine, high tar, fil-
ter cigarettes (University of Kentucky). The cigarettes
were smoked using a Borgwaldt RM2 apparatus accord-
ing to ISO determination parameters. These require a
puff volume for each cigarette of 35 mL with duration
of 2s at intervals of 60s, with an airflow surrounding the
cigarette of ≅ 200 ± 30 mm/s. This protocol resulted in
approximately 8 puffs/cigarette. Stocks of smoke solu-
tion were obtained by drowning (using a vacuum pump)
the mainstream smoke from 40 cigarettes through 10 ml
of sterile phosphate buffered saline (PBS) (abbreviated
TS1). Tobacco smoke was then quantified as cigarette/
mL (c/mL). The resulting concentration of the stoke
solutions was ≅ 4c/mL. The stock solutions were used
immediately after preparation. Note that cells were put
in contact with the soluble smoke extract in cycles of
120 minutes for a total period of 12 hours/day where
each cycle was divided as described: 0-15 minutes (vita-
min pre-treatment or nothing); 15-75 minutes (TS expo-
sure or nothing if control), 75-120 exchange with TS-
free medium (including controls). Each set of cycles was
designed to deliver exposure to TS equivalent to that
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Media samples (TS and TS-free) were collected
throughout the cycles and stored for analysis.
Hydrogen peroxide preparation
Hydrogen peroxide solution (PERDROGEN
® 30% H2O2)
was purchased from Sigma-Aldrich (St. Louis, MO
63178; cat# 31642) and diluted to achieve the appropri-
ate final experimental concentrations (55, 220, and 385
μM respectively which are comparable to that yield by
5, 20, and 35 2R24 research cigarettes; 2-4 μM/mg of
tar [69,70]). Dulbecco’s Phosphate Buffered Saline
(Sigma-Aldrich, St. Louis, MO 63178; cat# D4031) con-
taining 36 mg sodium pyruvate, 50 mg streptomycin sul-
fate, 100 mg kanamycin monosulfate, 1000 mg glucose/
La n dC a C l 2 adjusted to a pH ≅ 7.5 was used to make
dilutions of hydrogen peroxide. The solutions were pre-
pared fresh before the experiment and maintained at 37°
C.
Ascorbic acid and a-tocopherol preparation
a-tocopherol (vitamin E, cat# AC42103-1000)a n d
ascorbic acid (vitamin C, cat# AC40147-1000), were
purchased from Fischer Scientific Pittsburgh, PA. 43.07
mg of a-tocopherol were dissolved in 10 mL of ethanol
yielding a stock solution of 10 mM. The experimental
concentration of a-tocopherol (40 μM) was achieved by
diluting 4 μL of the stock solution in 1 mL of the speci-
fic growth medium. Ascorbic acid (35.22 mg) was
instead dissolved in 10 mL of PBS yielding a stock solu-
tion of 20 mM. Final experimental concentration of
ascorbic acid (80 μM ) was achieved by diluting 4 μLo f
the stock solution in 1 mL of the specific growth med-
ium. In the described experiments cells were pre-treated
with vitamin C and E (at a final concentration of 80 μM
and 40 μM respectively) prior exposure to soluble
tobacco smoke extract.
Cell Culture
Normal human brain microvascular endothelial cells
(HBMEC, cat# 1000), and human astrocytes (HA, cat#
1800) were purchased from ScienCell Research Labora-
tories, San Diego, CA 92121. HBMEC were expanded in
75 cm
2 flasks pre-coated with fibronectin (3 μg/cm
2)
using Endothelial Basal Medium MCDB 105 (Sigma,
Cat# M6395) containing 10% human AB serum (SIGMA,
Cat# S-7148), 15 mg/100 ml of endothelial cell growth
supplement (ECGS, Cat.# 1052), 800 units/ml of heparin
(Sigma, cat# H3393), 100 units/ml penicillin G sodium
and 100 mcg/ml streptomycin sulfate. Prior to use
HBMEC were characterized by immunocytochemistry
using sheep polyclonal antibodies that recognized the
human Von Willebrand Factor Antigen VIII (vWF/Factor
VIII, US biological, Swampscott, MA, cat# F0016-13A).
HA were grown in Poly-d-Lysine pre-coated flasks (3
μg/cm
2) with Dulbecco’s modified essential media
(DMEM-F12) supplemented with 2mM glutamine, 5%
fetal bovine serum (FBS), 100 units of sodium penicillin
G per ml, and 100 mcg of streptomycin sulfate per ml.
To obtain a highly purified astrocytic population Cyto-
sine arabinoside and L-leucine methyl ester (Sigma-
Aldrich, MO, USA) were added [95] and HA cultures
were agitated overnight at 37°C. We used rabbit polyclo-
nal antibodies specific for the glial cell marker glial
fibrillary acidic protein (GFAP, Dako Corporation, Car-
pentaria, CA, USA) to assess the purity of the HA cul-
tures which resulted > 95%. Both endothelial cells and
astrocytes were maintained at 37°C in a humidified
atmosphere with 5% CO2.N o t et h a tc e l l sw e r en o t
expanded for more than 2 cycles to minimize cell
dedifferentiation.
The human monocytic leukemia cell line (THP-1,
Cat# TIB-202) was purchased from American Type Cul-
ture Collection (ATCC, Manassas, VA). THP-1 cells
were grown at 37 °C in 95% air-5%CO2 in basal medium
(ATCC-formulated RPMI-1640 Medium, Catalog No.
30-2001) plus 0.05mM 2-mercaptoethanol and 10% fetal
bovine serum as specified by the vendor.
DIV-BBB setup
HBMEC and HA were cultured in a dynamic model of
the blood-brain barrier (DIV-BBB) in polypropylene or
on hollow fiber capillaries, as previously described (see
Figure 8). Briefly, the luminal surface of the hollow
fibers was pre-coated with 3 μg/cm
2 fibronectin to allow
HBMEC adhesion. The abluminal surface of the fibers
was pre-coated with 3 μg/cm
2 of poly-D-lysine to pro-
mote HA adhesion. HBMEC were first introduced into
the luminal compartment and allowed to adhere for 3
hrs without pulsatile flow. To maximize HBMEC adhe-
sion, the flow of medium was initiated in the abluminal
compartment for 24 hrs, then switched to pass directly
over the HBMEC in the luminal compartment at a low
level shear stress (2 dyne/cm
2) for another 24 hours.
The shear stress was then raised to a constant value of
4 dyne/cm
2. HA were seeded on the abluminal surface
of the fibers three days after HBMEC were loaded. Typi-
cally, two weeks of co-culture are required to establish a
fully functional BBB with a TEER greater than 800 Ω
cm
2 above the baseline (measured as TEER in a cell-free
module).
TEER measurement
TEER measurement provides a rapid, simple evaluation
of the integrity of the DIV-BBB. Our TEER measure-
ment device was purchased from Flocel (Flocel Inc., Cle-
veland, OH 44103). This system utilizes electronic
multiplexing to test multiple DIV-BBB modules in rapid
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t h ec o r es y s t e ma r ea v a i l a b l eo nt h ew e b s i t eo ft h e
maker of the device (http://www.Flocel.com). We have
previously verified that this method documents a strong
inverse relationship between TEER and permeability
across the EC monolayer in the DIV-BBB modules
[66-68].
Measurement of nitric oxide (NO)
Changes in nitric oxide (NO) were measured by
amperometric determination using an optically isolated
multi-channel free radical analyser (World Precision
Instruments, Sarasota, FL). The NO measuring probe is
inserted into the lumen downstream from the hollow
fiber apparatus and another probe in the ECS compart-
ment. NO is detected as previously described [96,97].
The on-line changes in NO were continuously measured
using a PC-driven system. Based on internal calibration
reading conversion of the NO sensors was ≅ 1.5pA/nM
of NO. Max sensitivity ≅ 50 fA according to the
manufacturer.
Measurement of cytokines and MMPs
Samples of medium from the luminal compartment
were centrifuged at 5,000 g for 5 min and stored at -20
°C until analysis. Levels of IL-6, IL-1b,a n dT N F - a were
measured by ELISA (cat# IB39673 (IL-6); # IB39654 (IL-
1b; # IB39699 (TNF-a); IBL America, Minneapolis, MN)
according to the manufacturer’s protocols. MMP-2 and
MMP-9 were also quantified by ELISA (cat# QIA63-
1EA (MMP-2) and QIA56-1EA (MMP-9); Calbiochem,
San Diego, CA). Final calculation of cytokine levels (pg/
mL) took into consideration time and volume of the
luminal compartment according to the formula: (VtxCc)-
(VnxCn)+(VtotalxCp)/Tc-Tp, where V represents added
volume of media (mL); C refers to the concentration of
a cytokine/MMP level (pg/mL); T is time of sampling
(in fraction of days: c and p indicate the current and pre-
vious samples, respectively; and n represents cytokine
values in the fresh medium added after each sampling.
Flow cytometry (FACS) and data analysis
TS-exposed and control endothelial cells were rinsed
with PBS. Cells were then gently mixed with chelation
buffer (1mM EDTA prepared in Ca
2+/Mg
2+ free PBS)
using a pipette tip washed in FACS buffer. (PBS+0.5%
BSA+0.02% NaN3) and resuspended to approx. 1 million
cells/100 μl. Cells were incubated with fluorescein di-
isothiocyanate conjugated anti-P-selectin, phycoerythrin-
conjugated anti-E-selectin, or alkaline phosphatases con-
jugated anti-VCAM-1 (respectively, cat.#555524; #
551144; #551146; BD Biosciences, San Jose, CA) for 20
minutes in the dark. Unbound antibody was removed by
several washes with FACS buffer. Cells were then resus-
pended in 200 μl of FACS buffer/sample for analysis
and data were calculated by Flow Jo 6.1.1 (Tree Star) for
Mac OS X. THP-1 cell suspensions were similarly tested
for CD45/CD14 (cat. #340040; BD Biosciences).
Matrix metalloproteinase activity
Aliquots of medium from the luminal compartment
were centrifuged at 14,000 g for 15 min at 4 °C and any
cell pellet discarded. Total protein content of the med-
ium was determined by Bradford assay. Gelatin zymo-
graphy of electrophoresed medium samples was carried
out on 7.5% polyacrylamide gels copolymerized with 2
g/L 90 Bloom Type A gelatin from porcine skin
(Sigma). After electrophoresis, gels were washed in Tri-
ton X-100 (2.5 mL/L) and incubated for 24 h (37 °C) in
enzyme buffer (50 mM Tris-HCl, pH 7.5; 5 mM CaCl2;
Figure 8 Schematic of a DIV-BBB module. A bundle of porous polypropylene hollow fibers is suspended in the DIV-BBB chamber. The artificial
capillaries are in continuity with a medium source through a flow path consisting of gas-permeable silicon tubing. Ports positioned on either
side of the module allow access to the luminal and abluminal compartments. Note how this artificial capillary system closely mimics the
physiology of the BBB in situ.
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®-35; 2.5 mL
Triton X-100; and 0.02 g/Lf NaN3). Gels were stained
with 0.5% Coomassie Blue R-250. Lysis bands were mea-
sured densitometrically with an image analyzer.
Statistical analysis
For parametric variables (e.g., TEER levels, glucose con-
sumption, lactate production, cytokines levels), differ-
ences between populations were analysed by ANOVA. p
values < 0.05 were considered statistically significant.
Bonferroni analysis was used to account for comparisons
of multiple parameters among groups. For non-para-
metric indices (e.g. densitometries for zymogram), we
used the Kruskal-Wallis test followed by Mann-Whitney
U-test. We used four cartridges per data point. Based
upon previous experiments, this number of cartridges
provided sufficient power to demonstrate statistical
significance.
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